What's new in prostate cancer?

• Risk-adapted screening and treatment of screen-detected PCa: A review of evolving screening strategies, risk group management, and the efficacy of current and future screening methods. Major trials like PROSCREEN and PROBASE will be discussed. Chairs: Prof. Peter Albers (DE) and Prof. Arnauld Villers (FR), Saturday 6 April, 08:00 - 10:00 CEST
• Personalised approaches in high-risk and metastatic PCa: Details the tailoring of treatments based on morphological and genomic features, interpreting PSMA-PET scans optimally, and debating the omission of PLND. Discussions extend to personalised treatments for biochemical relapse and metastatic disease, including PARP inhibitor use in mCRPC. Chairs: Prof. Silke Gillessen (CH) and Prof. Alberto Briganti, Milan (IT), Sunday 7 April, 08:00 - 10:00 CEST

More sessions on prostate cancer at EAU24:

• Thematic Session by EAU Policy Office (PRAISE-U)
  Chairs: Prof. P. Albers (DE) and Prof. H. Van Poppel (BE)
  Saturday 6 April, 10:45 - 12:15 CEST
• Thematic Session: Impact of EAU prostate cancer guidelines
  Chairs: Prof. P. Cornford (GB) and Prof. S. Gillessen (CH)
  Sunday 7 April, 10:45 - 12:15 CEST
• ESU Course 27: Prostate cancer update 2023-2024
  Chair: Prof. F. Montorsi (IT)
  Sunday 7 April, 08:30 - 11:30 CEST - separate registration required
• Game changing session: Lymph node dissection in prostate cancer: Is the book closed?
  Presenters: Prof. K. Touijer (US) and Prof. A. Deschamps (BE)
  Sunday 7 April, 10:00 - 10:30 CEST
• Joint Session of the EAU and the Advanced Prostate Cancer Consensus (APCCC)
  Chairs: Prof. S. Gillessen (CH) and Prof. B. Tombal (BE)
  Sunday 7 April, 13:30 - 15:30 CEST
• EGPT 11: Prostate cancer screening - Prime time for organising screen strategies?
• Abstract Session 29: Intensifying treatment for better PCa control
• Abstract Session 32: Prostate cancer screening at its best

See the full EAU24 scientific programme for more details.